Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 82, 158-170
Abstract
No abstract availableKeywords
Funding Information
- University of Nebraska Medical Center
- National Institutes of Health (EB020308, DK088902)
- National Cancer Institute (P30 CA036727)
This publication has 57 references indexed in Scilit:
- A clinical review of recent findings in the epidemiology of inflammatory bowel diseaseClinical Epidemiology, 2013
- Dextran Sodium Sulfate Inhibition of Real-Time Polymerase Chain Reaction Amplification: A Poly-A Purification SolutionInflammatory Bowel Diseases, 2012
- The Pathogenicity of an EntericCitrobacter rodentiumInfection Is Enhanced by Deficiencies in the Antioxidants Selenium and Vitamin EInfection and Immunity, 2011
- The dextran sulphate sodium (DSS) model of colitis: an overviewComparative Clinical Pathology, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- In Vivo Bioluminescence Imaging of the Murine Pathogen Citrobacter rodentiumInfection and Immunity, 2006
- Medical Treatment of Ulcerative ColitisClinics in Colon and Rectal Surgery, 2004
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Clinical Pharmacokinetics and Metabolism of ChloroquineClinical Pharmacokinetics, 1996
- Very low intraluminal colonic pH in patients with active ulcerative colitisDigestive Diseases and Sciences, 1993